It is estimated that ≈70% or more of human cancers have Myc overexpressed or deregulated in other ways that lead to elevated Myc activity in tumor cells.[34–36,37] Elevated Myc protein is known to expand its interactions within the genome,[33,38] and presumably this would be met with increased interactions with MCMs/CMGs. This evidence concerns the gene MYC and cancer.